Reckitt Benckiser Group plc (RBGLY)
| Previous Close | 15.17 |
| Open | 15.24 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 15.24 - 15.27 |
| 52 Week Range | 12.71 - 16.78 |
| Volume | |
| Avg. Volume | 683,620 |
| Market Cap | 54.666B |
| Beta (5Y Monthly) | 0.13 |
| PE Ratio (TTM) | 18.85 |
| EPS (TTM) | 0.81 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.43 (2.91%) |
| Ex-Dividend Date | Apr 10, 2023 |
| 1y Target Est | 17.25 |
- Simply Wall St.
Reckitt Benckiser Group plc Just Missed EPS By 6.3%: Here's What Analysts Think Will Happen Next
As you might know, Reckitt Benckiser Group plc ( LON:RKT ) recently reported its yearly numbers. Revenues of UK£14b...
- Reuters
UPDATE 4-Reckitt's sales beat estimates on higher prices, infant formula
Reckitt Benckiser, maker of Dettol and Lysol cleaning products, on Wednesday marginally beat full-year like-for-like net revenue expectations, helped by higher prices and its nutrition and health businesses. The company said it would target like-for-like net revenue growth of mid-single digits for 2023, excluding the substantial boost its 2022 sales received from the recall of a rival's infant formula. Abbott Laboratories early last year recalled dozens of infant nutrition products in the United States after customers complained of infants contracting bacterial infections.
- Reuters
Reckitt's sales beat estimates on higher prices, infant formula
Reckitt Benckiser, maker of Dettol and Lysol cleaning products, on Wednesday marginally beat full-year like-for-like net revenue expectations, helped by higher prices and its nutrition and health businesses. The company said it would target like-for-like net revenue growth of mid-single digits for 2023, excluding the substantial boost its 2022 sales received from the recall of a rival's infant formula. Abbott Laboratories early last year recalled dozens of infant nutrition products in the United States after customers complained of infants contracting bacterial infections.
